Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 1 , Pages 51-63 , March 2005

PD/PDT for gynecological disease: A clinical review

  • R.R. Allison

      Affiliations

    • Department of Radiation Oncology, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • PDT Center, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • ,
  • R. Cuenca

      Affiliations

    • PDT Center, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • Surgical Oncology Department, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • ,
  • G.H. Downie

      Affiliations

    • PDT Center, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • Pulmonary and Critical Care Medicine Department, The Brody School of Medicine at East Carolina University, Greenville, 600 Moye Blvd., LJCC 172, NC 27858, USA
    • ,
  • M.E. Randall

      Affiliations

    • Department of Radiation Oncology, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • PDT Center, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • ,
  • V.S. Bagnato

      Affiliations

    • University of São Paulo-São Carlos, Physics Department, São Carlos, SP, Brazil
    • ,
  • C.H. Sibata, PhD

      Affiliations

    • Department of Radiation Oncology, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • PDT Center, The Brody School of Medicine at East Carolina University, 600 Moye Blvd., LJCC 172, Greenville, NC 27858, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 252 744 2900; fax: +1 425 940 3498.

References 

  1. Hoskins . In: 4th ed..  Barakat RR,  Markman MR editor. Principles and practice of gynecologic oncology. vol. 1:Lippincott, Williams & Wilkins; 2004;p. 1131
  2. Allison RR, et al. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin Cutan Med Surg. 1998;17(2):153–163
  3. Stringer M, Moghissi K. Photodiagnosis and fluorescence imaging in clinical practice. Photodiagn Photodyn Ther. 2004;1(1):9–12
  4. Sibata CH, et al. Photodynamic therapy: a new concept in medical treatment. Braz J Med Biol Res. 2000;33(8):869–880
  5. Sibata CH, et al. Photodynamic therapy in oncology. Expert Opin Pharmacother. 2001;2(6):917–927
  6. Dougherty TJ, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889–905
  7. Allison RR, et al. Photosensitizers in clinical PDT. Photodiagn Photodyn Ther. 2004;1(1):27–42
  8. Peng Q, et al. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;65(2):235–251
  9. Peng Q, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79(12):2282–2308
  10. Mang T. Lasers and light sources for PDT: past, present and future. Photodiagn Photodyn Ther. 2004;1(1):43–48
  11. Dickey DJ, et al. Light dosimetry for multiple cylindrical diffusing sources for use in photodynamic therapy. Phys Med Biol. 2004;49(14):3197–3208
  12. Downie GH, et al. A comparison of interstitial and superficial light delivery for photodynamic therapy of intraluminal neoplasms. J Bronchol. 2002;9(3):193–196
  13. Andersson-Engels S, et al. Preliminary evaluation of two fluorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin. Lasers Surg Med. 2000;26(1):76–82
  14. Lam S, et al. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer. 2000;89(11 Suppl.):2468–2473
  15. Bigio IJ, Mourant JR. Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy. Phys Med Biol. 1997;42(5):803–814
  16. Breslin TM, et al. Autofluorescence and diffuse reflectance properties of malignant and benign breast tissues. Ann Surg Oncol. 2004;11(1):65–70
  17. Richards-Kortum R, et al. In vivo fluorescence spectroscopy: potential for non-invasive, automated diagnosis of cervical intraepithelial neoplasia and use as a surrogate endpoint biomarker. J Cell Biochem Suppl. 1994;19:111–119
  18. Richards-Kortum R, Sevick-Muraca E. Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem. 1996;47:555–606
  19. Huh WK, et al. Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study. Am J Obstet Gynecol. 2004;190(5):1249–1257
  20. Zuluaga A, et al. Fluorescence excitation emission matrices of human tissue: a system for in vivo measurement and method of data analysis. Appl Spectrosc. 1999;53(3):302–311
  21. Chang SK, et al. Analytical model to describe fluorescence spectra of normal and preneoplastic epithelial tissue: comparison with Monte Carlo simulations and clinical measurements. J Biomed Opt. 2004;9(3):511–522
  22. Palmer GM, et al. Autofluorescence spectroscopy of normal and malignant human breast cell lines. Photochem Photobiol. 2003;78(5):462–469
  23. Singer A, et al. A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation. Int J Gynecol Cancer. 2003;13(6):804–811
  24. Allison RR, Mota HC, Sibata CH. Clinical history of PDT in North America: an historical overview. Photodiagn Photodyn Ther. 2005;1:263–277
  25. Jesionek A, Von Tappeiner H. On the treatment of skin cancers with fluorescent substances. Arch Clin Med. 1905;82:223–227
  26. Auler H, Banzer G. Untersuchungen uber die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z Krebsforsch. 1942;53:65–68
  27. Mack HP, et al. Evaluation of the combined effects of hematoporphyrin and radiation. I. Treatment of carcinoma of the cervix. Cancer. 1957;10(3):529–539
  28. Schwartz SK, et al. Some relationship of porphyrins, X-rays and tumors. Univ Minn Med Bull. 1955;27:7–8
  29. Lipson RL, Baldes EJ. The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol. 1960;82:508–516
  30. Gray MJ, et al. Use of hematoporphyrin derivative in detection and management of cervical cancer. Am J Obstet Gynecol. 1967;99(6):766–771
  31. Mossman BT, et al. Identification of neoplastic versus normal cells in human cervical cell culture. Obstet Gynecol. 1974;43(5):635–639
  32. Lipson RL, et al. Hematoporphyrin derivative for detection and management of cancer. Cancer. 1967;20(12):2255–2257
  33. Dougherty TJ, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38(8):2628–2635
  34. Ciotti M, et al. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Eur J Gynaecol Oncol. 2004;25(5):577–584
  35. Frazer IH, et al. Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIXtrade mark adjuvant in women with cervical intraepithelial neoplasia. Vaccine. 2004;23(2):172–181
  36. Hagen B, et al. CO2 laser conization for cervical intraepithelial neoplasia grade II–III: complications and efficacy. Acta Obstet Gynecol Scand. 1998;77(5):558–563
  37. Hagen B, Skjeldestad FE. The outcome of pregnancy after CO2 laser conisation of the cervix. Br J Obstet Gynaecol. 1993;100(8):717–720
  38. Lipson RL, et al. Further evaluation of the use of hematoporphyrin derivative as a new aid for the endoscopic detection of malignant disease. Dis Chest. 1964;46:676–679
  39. Lipson RL, et al. Hematoporphyrine derivative for detection of cervical cancer. Obstet Gynecol. 1964;24:78–84
  40. Andikyan V, et al. Fluorescence diagnosis with 5-ALA thermogel of cervical intraepithelial neoplasia. Gynakol Geburtshilfliche Rundsch. 2004;44(1):31–37
  41. Muroya T, et al. Photodynamic therapy (PDT) for early cervical cancer. Gan To Kagaku Ryoho. 1996;23(1):47–56
  42. Ichimura H, et al. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Int J Clin Oncol. 2003;8(5):322–325
  43. Monk BJ, et al. Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasia. Gynecol Oncol. 1997;64(1):70–75
  44. Anderson MC, Hartley RB. Cervical crypt involvement by intraepithelial neoplasia. Obstet Gynecol. 1980;55(5):546–550
  45. Pahernik SA, et al. Pharmacokinetics and selectivity of aminolevulinic acid-induced porphyrin synthesis in patients with cervical intra-epithelial neoplasia. Int J Cancer. 1998;78(3):310–314
  46. Barnett AA, et al. A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia. Int J Cancer. 2003;103(6):829–832
  47. Hillemanns P, et al. Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Int J Cancer. 1999;81(1):34–38
  48. Keefe KA, et al. Fluorescence detection of cervical intraepithelial neoplasia for photodynamic therapy with the topical agents 5-aminolevulinic acid and benzoporphyrin-derivative monoacid ring. Am J Obstet Gynecol. 2001;184(6):1164–1169
  49. Keefe KA, et al. Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid. Lasers Surg Med. 2002;31(4):289–293
  50. Bodner K, et al. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. Anticancer Res. 2003;23(2C):1785–1788
  51. Wierrani F, et al. 5-Aminolevulinic acid-mediated photodynamic therapy of intraepithelial neoplasia and human papillomavirus of the uterine cervix—a new experimental approach. Cancer Detect Prev. 1999;23(4):351–355
  52. Dougherty TJ. Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol. 1981;77(1):122–124
  53. Lele SB, et al. Photodynamic therapy in gynecologic malignancies. Gynecol Oncol. 1989;34(3):350–352
  54. Hillemanns P, et al. Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. Am J Obstet Gynecol. 2000;183(1):52–57
  55. Gannon MJ, et al. Photosensitization of the endometrium with topical 5-aminolevulinic acid. Am J Obstet Gynecol. 1995;173(6):1826–1828
  56. Hornung R, et al. Uptake of the photosensitizer benzoporphyrin derivative in human endometrium after topical application in vivo. J Am Assoc Gynecol Laparosc. 1998;5(4):367–374
  57. Dwyer PJ, et al. Optical integrating balloon device for photodynamic therapy. Lasers Surg Med. 2000;26(1):58–66
  58. Koren H, Alth G. Photodynamic therapy in gynaecologic cancer. J Photochem Photobiol B. 1996;36(2):189–191
  59. Lobraico RV, Grossweiner LI. Clinical experiences with photodynamic therapy for recurrent malignancies of the lower female genital tract. J Gynecol Surg. 1993;9(1):29–34
  60. Rettenmaier MA, et al. Photoradiation therapy of gynecologic malignancies. Gynecol Oncol. 1984;17(2):200–206
  61. Rettenmaier MA, et al. Gynecologic uses of photoradiation therapy. Prog Clin Biol Res. 1984;170:767–775
  62. Joura EA. Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia. Curr Opin Obstet Gynecol. 2002;14(1):39–43
  63. Fehr MK, et al. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. Am J Obstet Gynecol. 1996;174(3):951–957
  64. Fehr MK, et al. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med. 2002;30(4):273–279
  65. Frank RG, Bos JD. Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. Genitourin Med. 1996;72(1):70–71
  66. Wang XL, et al. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol. 2004;151(4):880–885
  67. Akoel KM, et al. Photodynamic diagnosis of vulvar precancerous conditions and invasive cancers using 5-aminolevulinic acid. Ginekol Pol. 2003;74(9):662–665
  68. Fehr MK, et al. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Gynecol Oncol. 2001;80(1):62–66
  69. Kurwa HA, et al. Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy. Br J Dermatol. 2000;143(5):1040–1042
  70. Abdel-Hady ES, et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 2001;61(1):192–196
  71. Martin-Hirsch P, et al. Photodynamic therapy of lower genital tract neoplasia. Gynecol Oncol. 2002;84(1):187–189
  72. Martin-Hirsch PL, et al. Photodynamic treatment for lower genital tract intraepithelial neoplasia. Lancet. 1998;351(9113):1403
  73. Hillemanns P, et al. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int J Cancer. 2000;85(5):649–653
  74. Campbell SM, et al. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia. Br J Dermatol. 2004;151(5):1076–1080
  75. Hillemanns P, et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol. 1999;93(1):71–74
  76. Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol. 2000;142(1):59–65
  77. Levenback C, et al. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001;83(2):276–281
  78. Levenback C, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002;20(3):688–693
  79. McCaughan JS, et al. Photodynamic therapy of gynecologic neoplasms after presensitization with hematoporphyrin derivative. Lasers Surg Med. 1985;5(5):491–498
  80. Soma H, et al. Treatment of vaginal carcinoma with laser photoirradiation following administration of haematoporphyrin derivative. Report of a case. Ann Chir Gynaecol. 1982;71(2):133–136
  81. McCaughan L. Lasers in photodynamic therapy. Nurs Clin North Am. 1990;25(3):725–738
  82. Corti L, et al. Gynecologic cancer recurrences and photodynamic therapy: our experience. J Clin Laser Med Surg. 1995;13(5):325–328
  83. Krimbacher E, et al. Photodynamic therapy for recurrent gynecologic malignancy: a report on 4 cases. Arch Gynecol Obstet. 1999;262(3/4):193–197
  84. DeLaney TF, et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys. 1993;25(3):445–457
  85. Wierrani F, et al. Clinical effect of meso-tetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary: preliminary results. Br J Obstet Gynaecol. 1997;104(3):376–378
  86. Allison RR, et al. Photodynamic therapy for chest wall recurrence from breast cancer. Photodiagn Photodyn Ther. 2004;1(2):157–171
  87. Allison R, et al. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer. 2001;91(1):1–8
  88. Cuenca RE, et al. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol. 2004;11(3):322–327
  89. Khan SA, et al. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer. 1993;29A(12):1686–1690
  90. Schuh M, et al. Photodynamic therapy for palliation of locally recurrent breast carcinoma. J Clin Oncol. 1987;5(11):1766–1770
  91. Taber SW, et al. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J Surg Oncol. 1998;68(4):209–214
  92. Mang TS, et al. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am. 1998;4(6):378–384
  93. Wyss P, et al. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer. Int J Cancer. 2001;93(5):720–724

PII: S1572-1000(05)00033-5

doi: 10.1016/S1572-1000(05)00033-5

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 1 , Pages 51-63 , March 2005

Article Tools